Bench-to-Market Life Science Provider

We support life science start-ups with a wide range of expertise, either in-house or via our network of pre-qualified experts, laboratories, CMOs, warehouses, logistic partners and affiliates.

We have the expertise needed to bring your product from the bench to the market.

Our development team will support you with Quality Assurance, Medical and Regulatory Affairs, Clinical Operations, Biostatistics, Medical Writing and eSubmissions.

Once you’re coming closer to the market, we offer customized Marketing and Business Development activities.


Join our successful 6-step incubation program and we’ll coach you all the way on your journey from “green to gold” 

As an experienced team that made pivotal contributions to the approval of several healthcare products, we know exactly what is needed to bring a new product to the market.

Start-ups can enter the program at any stage and no two projects are ever the same.


Your journey starts here. Ready to incorporate and not sure about the next steps? Come and see us, we offer an unbeatable one-stop-shop solution!

  • 1-5 founders
  • We give you some first advice for free
  • We help you apply for the Innosuisse coaching program
  • We discuss your financing options and show you how to get there
  • Our in-house notary and accountant will support you with incorporation and setting up your accounts
  • Our IP lawyers advise you on your patents and brands strategy


Our lawyer and notary will help you draft all documents and guide you through the process of incorporation.

  • 2-5 first employees
  • You can join our incubator in Liestal (rent-a-desk or full-service virtual office)
  • We discuss with you the best way to get to market approval
  • We help you negotiate a license agreement with the university
  • We help you write a business and development plan
  • We help you find Seed financing


Now is the time to put your plans into reality and continue with the product development. HEMEX will help you with all steps that are needed.

  • 5-10 employees
  • We help you with Series A financing
  • We set up your Quality Management System and perform (mock-)audits
  • We partner with you for non-dilutive grants
  • We support your product development with preclinical and clinical operations
  • We help you CE-mark your medical device or get positive CHMP/FDA opinion


First sales! Profit is still a bit down the road, though. Scale up is needed, but growing pains are real. We’ll help you go international.

  • 10-50 employees
  • Obtain approval in your first market!
  • We help you with Series B financing
  • We help you develop an international (transfer) pricing strategy
  • We help you develop an approval and reimbursement strategy in the 7MM
  • We help you setting up licensing or co-marketing deals


Your business is sustainable now. Your “baby” has become an adolescent and it’s time to start thinking of letting go!

  • 50-200 employees
  • We help you complementing the founder team with internationally experienced C-level executives who can guide the company through the next stage
  • We help you with market access and insight services in order to boost sales
  • We help you find strategic partners and investors with merger and acquisition capabilities


It’s time to reap the fruits of your hard work! We help you with the different options to cash in on your investment.

  • >200 employees
  • We help you implementing your exit strategies
  • Further financing via a co-development or co-marketing partner
  • Trade sale to a larger market player
  • Initial Public Offering

We invest in selected life science start-ups, in cash and/or in kind. 

We combine development and fundraising skills, to offer you a distinctive advantage when interacting with the investor community. We are a knowledgable and reliable partner for investors to oversee their financial commitment. We offer workshops with our in-house accredited Innosuisse special coach to help you with your first financing rounds.

What our start-ups say

Hemex provides Scailyte a range of services, from administrative to highly specialized regulatory and clinical development support. Working at Hemex incubator, whenever we have a question, we can immediately address it. We’re happy to continue our journey with such a trusted partner.

From the start of Resistell, Hemex supports our company in the clinical operations and also back us with its investment arm. The understanding of startup needs, makes Hemex a unique partner in our journey to the market.

Hemex has been instrumental in Annaida Technologies’ progress. They were the first to recognize our potential and acted swiftly to support us in our development. We wouldn’t be where we are without their help.

Hemex supports us in marketing and sales, negotiating with industry partners and regulations. Their team is highly dedicated and delivers always on time and in high quality. Hemex is giving us the support we wished for.

Advancience combines psychology, neuroscience, and informatics to make game-based assessments for the psychological assessment industry, both as HR tools as well as diagnostic test, e.g. for ADHD.

Annaida Technologies logo

One in 10 couples experiences difficulties conceiving a child. Annaida’s patented NMR technology gives fertility doctors the ability to perform a fast, non-invasive and quantitative embryo screening, providing patients with an improved overall IVF experience.

The ARTIDISNet platform uses a nanomechanical sensor that captures the physical properties of tissue enabling the clinician to differentiate between benign and malignant tissue from biopsies in cancer patients in under three hours.

BioReperia logo

BioReperia, based in Sweden and Switzerland, offers a highly precise, humanized zebrafish model to the pharmaceutical industry, to evaluate the safety and efficacy of oncology drug candidates in vivo, getting results as early as within a week.

haako breathe asthma app logo

Haako’s holistic asthma management solution Breathe helps parents of children with asthma. Allowing parents to track and better understand their child’s condition, they can make informed care decisions that achieve better patient outcome for children and less stress to parents.

ender provides rapid and reliable testing kits for acute COVID–19 capable of diagnosing multiple samples at once and within just 30 minutes. These tests can be used in hospitals as well as right on-site.


GeoHealthApp logo

geoHealthApp GmbH developed an App that has the potential to stop the spread of COVID19. An interactive map shows areas with high infection rates that can be evaded by the user. Based on anonymous smartphone location data and AI, users learn if they have been in contact with infected people during the last 14 days. The Beta Version has been launched in Germany, Switzerland, Austria, UK and USA.

GeneLook allows patients suffering from rare diseases to access their DNA profile using their smartphone, using it for personalized healthcare and health alerts. In exchange, GeneLook’s business model will also give pharmaceutical companies access to this data to develop new therapies.

Hi-D Imaging AG is an ETH spin-off that aims to revolutionize the cardiovascular sector by making personalized heart valve replacement therapy a reality. Developing the world’s first AI-based pre-operational planning platform that assesses different heart valves for the patient specific anatomy before the surgery, Hi-D will provide detailed report on the optimum shape and size of the valve to the clinician. Their technology will increase the life quality of the patient, decrease after-surgery complications, reduce the long-term costs, and increase the success rate of the surgery, as well as optimize the design of next generation heart valves.

Inura Medical developed a urethral suppository with an approved pharmaceutical agent to help patients  who are suffering from two highly prevalent and disabling health disorders: overactive bladder (OAB) and nocturia.

MOMM Diagnostic’s patented technology is used to early detect a biomarker for pre-eclampsia (PE), a pregnancy disorder that can have devastating effects on the health of the mother and the unborn baby. Affecting 5-8% of all pregnancies, pre-eclampsia is a rapidly progressive and potentially deadly condition.

LiVET develops and produces rapid molecular point-of-care diagnostic tests for the veterinary market. Based on LiVET’s proprietary platform technology, veterinarians can diagnose infectious diseases and parasites directly on-site within just 30 minutes. The test kits run on commercially available devices that enables the user to test up to 16 samples at once. This allows for immediate and specific treatment. The first test panel for respiratory diseases in horses includes Strangles, EHV 1+4 and Influenza and will be available in 2020.

Resistell logo

Resistell’s life-saving technology is based on the detection of movement caused by living bacterial cells and provides information on which antibiotic should be used to treat the patient, and the concentration at which it should be administered.

Scailyte’s multi-disciplinary team is applying a data-driven approach to discover novel biomarkers and develop a new generation of precision diagnostics based on single-cell data and AI.

Sleepiz’s diagnostic device uses millimeter wave technology, sensor fusion, and machine learning to measure vital signs in a contactless and medical grade manner at home, completely changing the way disorders lie sleep apnea are diagnosed.

STIMIT develops a non-invasive medical device that enables ICU patients to breath by stimulating diaphragm contractions, therefore creating natural breath instead of pumping air into the lungs with a machine. With this new therapy, the breathing muscle remains active and strong.



At Hemex we are dedicated to helping startups succeed. We partner with exceptionally motivated experts from business and life sciences, providing a combined knowledge platform with a considerable potential for new businesses.


Healthcare Management Experts

Each of our associates can rely on several years of specialized experience in the Life Science industry. In order to support your project from its inception to a future exit, we cover a broad area of expertise, ranging from clinical, quality and regulatory operations to financial, legal and business development.

Medical / Ra







Hans Zulliger Quality QP

Quality & QP


Digital Media

Dr. Philipp Marchand

IP Consultant


IP Consultant

Digital Media








Medical Innovation

Market Insights

Postdoc (Ph.D.) Opportunity in Molecular Biology (m/f)


Location: Inselspital – University Hospital Bern / Switzerland

Our portfolio company Scailyte is offering in collaboration with the University Hospital in Bern a postdoctoral research position in the laboratory of Endometriosis and Gynecological Oncology.

Position objects - Requirements

Scailyte and the University Hospital Bern are looking for an independent and strongly motivated researcher with a PhD or MD/PhD degree, and experience in NGS and single-cell sequencing. Additional expertise for research projects involving human subjects, gynaecology, pain mechanisms, epithelial to mesenchymal transition or inflammation would be highly desirable. The ideal candidate is an adaptable team-player and has excellent communication and organizational skills. In this exciting role the candidate will have the unique opportunity to drive a discovery project addressing an enormous medically unmet-need using cutting edge genomic technology combined with machine learning based data analytics.

As post-doctorant you will take part into a project aiming to develop a non-invasive single-cell molecular in vitro diagnostic test for endometriosis. This work will consist mainly into preparation of single-cell suspensions, construction of gene expression libraries and analysis of the immune profile and transcriptome at the cellular level using the 10X genomics platform.

This project will provide multiple opportunities for collaborations and cross-disciplinary scientific exchanges. Meanwhile, the candidate should have excellent communication skills (particularly in English) and should be familiar with the constraints related to translational researches, in particular regarding deadlines. Aptitude to drive and maintain intra and inter team collaborations will be highly appreciated.

An interesting aspect for your carrier, you will have the possibility to develop your own research program taking advantage of our large biobank and of the expertise of our physicians.

The Package
The proposed project is a funded collaboration between Inselspital and Scailyte AG, a Swiss Top100 startup company focusing on leveraging single-cell technologies and artificial intelligence (AI) data analytics to develop next-generation in vitro diagnostics.

The position is limited to 2 years with a possibility of extension. To successfully reach your objectives dedicated technical support will be made available to you. The position will remain open until a suitable candidate will be recruited.

How to apply

Please submit: CV, list of publications, motivation letter, description of your research interests, copies of PhD or MD/PhD degree and the names and telephone numbers of three referees.

For more information and to apply online click HERE


Freelance Experts

20-40% for flexible assignments

Location: Europe

Candidate Profile
  • At least 3-5 years’ hands-on experience in the fields of Quality Assurance, Regulatory Affairs or Clinical Operations (medical devices, IVD, animal health, digital health, small/large molecules)
  • Willing to help with the development of new human/animal medicines, pharmaceuticals, and/or medical devices/diagnostics
  • Eager to bring your expertise to a diverse, international team and learn different new skills
  • Self-motivated, willing to work independently home-based or at the client’s premises and meet pre-defined deadlines with a small team
  • Excellent communication skills, outgoing personality
  • Excellent organizational, interpersonal skills, and attention to detail
  • Experience using business tools, including Word, Excel, PowerPoint
Our offer
  • Join a small team of multinational, multidisciplinary, highly motivated experts
  • Modern, inclusive, pleasant working environment in a fast-growing, dynamic organization
  • Ability to independently manage your role and responsibilities
  • Opportunity to develop yourself and support start-ups developing highly innovative therapies
  • Office-based employment in Liestal (Switzerland), 7min by foot from Liestal SBB train station
  • Ability to work part-time, if desired
How to apply

Please send your CV in English, including supporting documents, by e-mail to info@hemex.ch


Our contact details

Office addresses

Hemex AG
Kasernenstrasse 30 | 4410 Liestal | Switzerland 

Hemex Germany GmbH
Marie-Curie-Str. 8 | 79539 Loerrach | Germany

Hemex, LLC
4800 Hampden Lane Suite 200 | Bethesda, MD 20814 | USA

E-Mail addresses

Hemex AG

Hemex Germany GmbH

Hemex, LLC

Telephone contact


Mo-Fri 09:00-17:00 CET, our headquarters can be reached under (+41) 61-927-28-00.


Mo-Fri 09:00-17:00 CET, our EU office can be reached under (+49) 1512-568-48-92.

United States of America:

Mo-Fri 9am-5pm Eastern Time, our team in Bethesda MD can be reached at (+1) 301-500-1535.

Outside business hours your call will be forwarded.


24/7/365 emergency phone numbers: 

(+41) 79-833-73-30 (Switzerland) 

(+49) 1512-568-48-92 (Germany)


Hotel Engel: 2 min. on foot (ask for preferred HEMEX rate)

Hotel Bad Bubendorf: 10 min. by car

Send us an e-mail